Lack of association of mirSNP rs11174811 in AVPR1A gene with arterial blood pressure and hypertension in South Indian population

References

• Koshimizu TA, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, et al. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci U S A. 2006;103(20):7807–12.
   PubMed Web of Science ®Google Scholar
• Caldwell HK, Lee HJ, Macbeth AH, Young WS. Vasopressin: behavioural Roles of an “original” neuropeptide. Prog Neurobiol. 2008;84(1):1–24.
   PubMed Web of Science ®Google Scholar
• Fernández-Varo G, Oró D, Cable EE, Reichenbach V, Carvajal S, De La Presa BG, Wiśniewski K, Ginés P, Harris G, Jiménez W. Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats. Hepatology. 2016;63(1):207–16.
   PubMed Web of Science ®Google Scholar
• Burrell LM, Risvanis J, Dean RG, Patel SK, Velkoska E, Johnston CI. Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertension. J Am Soc Hypertens. 2013;7(1):3–13.
   PubMed Web of Science ®Google Scholar
• Fujiwara Y, Tanoue A, Tsujimoto G, Koshimizu TA. The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice. Clin Exp Nephrol. 2012;16(1):30–34.
   PubMed Web of Science ®Google Scholar
• Cowley AW, Michalkiewiz M. Vasopressin and neuropeptide Y. In: Izzo JL, Sica DA, Black HR, editors. Hypertension primer. 4th ed. Philadelphia: American Heart Association and Lippincott Williams & Wilkins; 2008. p. 70–73.
   Google Scholar
• Marques FZ, Booth SA, Charchar FJ. The emerging role of non-coding RNA in essential hypertension and blood pressure regulation. J Hum Hypertens. 2015;29(8):459–67.
   PubMed Web of Science ®Google Scholar
• Bátkai S, Thum T. MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep. 2012;14(1):79–87.
   PubMed Web of Science ®Google Scholar
• Romaine SP, Charchar FJ, Samani NJ, Tomaszewski M. Circulating microRNAs and hypertension–from new insights into blood pressure regulation to biomarkers of cardiovascular risk. Curr Opin Pharmacol. 2016;27:1–7.
   PubMed Web of Science ®Google Scholar
• Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389–402.
   PubMed Web of Science ®Google Scholar
• Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hébuterne X, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease. Nat Genet. 2011;43(3):242–45.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang F, Li T, Lu M, Wang L, Yue W, Zhang D. MirSNP, database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics. 2012;13:661.
   PubMed Web of Science ®Google Scholar
• Nossent AY, Hansen JL, Doggen C, Quax PH, Sheikh SP, Rosendaal FR. SNPs in microRNA binding sites in 3’-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens. 2011;24(9):999–1006.
   PubMed Web of Science ®Google Scholar
• Krishnan MN, Zachariah G, Venugopal K, Mohanan PP, Harikrishnan S, Sanjay G, Jeyaseelan L, Thankappan KR. Prevalence of coronary artery disease and its risk factors in Kerala, South India: a community-based cross-sectional study. BMC Cardiovasc Disord. 2016;16:12.
   PubMed Web of Science ®Google Scholar
• Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19(1):149–50.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr. Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003;289(19):2560–72.
   PubMed Web of Science ®Google Scholar
• Koshy L, Anju AL, Harikrishnan S, Kutty VR, Jissa VT, Kurikesu I, Jayachandran P, Jayakumaran Nair A, Gangaprasad A, Nair GM, et al. Evaluating genomic DNA extraction methods from human whole blood using endpoint and real-time PCR assays. Mol Biol Rep. 2017;44(1):97–108.
   PubMed Web of Science ®Google Scholar
• Tanamas SK, Hanson RL, Nelson RG, Knowler WC. Effect of different methods of accounting for antihypertensive treatment when assessing the relationship between diabetes or obesity and systolic blood pressure. J Diabetes Complications. 2017;31(4):693–99.
   PubMed Web of Science ®Google Scholar
• Tobin MD, Sheehan NA, Scurrah KJ, Burton PR. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med. 2005;24(19):2911–35.
   PubMed Web of Science ®Google Scholar
• Sequeira-Lopez ML, Weatherford ET, Borges GR, Monteagudo MC, Pentz ES, Harfe BD, Carretero O, Sigmund CD, Gomez RA. The microRNA-processing enzyme dicer maintains juxtaglomerular cells. J Am Soc Nephrol. 2010;21(3):460–67.
   PubMed Web of Science ®Google Scholar
• Albinsson S, Skoura A, Yu J, DiLorenzo A, Fernández-Hernando C, Offermanns S, Miano JM, Sessa WC. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One. 2011;6(4):e18869.
   PubMed Web of Science ®Google Scholar
• Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE. MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage. J Am Soc Hypertens. 2014;8(6):368–75.
   PubMed Web of Science ®Google Scholar
• Cengiz M, Karatas OF, Koparir E, Yavuzer S, Ali C, Yavuzer H, Kirat E, Karter Y, Ozen M. Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore). 2015;94(13):e693.
   PubMed Web of Science ®Google Scholar
• Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3’ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet. 2007;81(2):405–13.
   PubMed Web of Science ®Google Scholar
• Fu X, Guo L, Jiang ZM, Zhao LS, Xu AG. An miR-143 promoter variant associated with essential hypertension. Int J Clin Exp Med. 2014;7(7):1813–17.
   PubMed Web of Science ®Google Scholar
• Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, Cross D, Gracey J, Hayes S, Smith T, et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation. 2005;112(22):3423–29.
   PubMed Web of Science ®Google Scholar
• Miranda JJ, Herrera VM, Chirinos JA, Gómez LF, Perel P, Pichardo R, González A, Sánchez JR, Ferreccio C, Aguilera X, et al. Major cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO). PLoS One. 2013;8(1):e54056.
   PubMed Web of Science ®Google Scholar
• Thomas IC, Ratigan AR, Rifkin DE, Ix JH, Criqui MH, Budoff MJ, Allison MA. The association of renal artery calcification with hypertension in community-living individuals: the multiethnic study of atherosclerosis. J Am Soc Hypertens. 2016;10(2):167–74.
   PubMed Web of Science ®Google Scholar
• Hasan KN, Shoji M, Sugimoto K, Tsutaya S, Matsuda E, Kudo R, Nakaji S, Suda T, Yasujima M. Association of novel promoter single nucleotide polymorphisms in vasopressin V1a receptor gene with essential hypertension in nonobese Japanese. J Hum Hypertens. 2007;21(10):825–27.
   PubMed Web of Science ®Google Scholar
• Thibonnier M, Graves MK, Wagner MS, Chatelain N, Soubrier F, Corvol P, Willard HF, Jeunemaitre X. Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol. 2000;32(4):557–64.
   PubMed Web of Science ®Google Scholar